Agilon Health (NYSE:AGL) Trading Down 10.1% – Should You Sell?

Agilon Health, Inc. (NYSE:AGL)’s stock price was down 10.1% during mid-day trading on Thursday . The company traded as low as $95.00 and last traded at $96.15. Approximately 51,126 shares were traded during trading, a decline of 85% from the average session volume of 349,669 shares. The stock had previously closed at $106.96.

Analysts Set New Price Targets

Several brokerages have recently issued reports on AGL. Barclays upgraded Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price target on the stock in a research note on Tuesday, May 26th. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. TD Cowen reaffirmed a “hold” rating and issued a $55.00 target price (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target for the company. in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and increased their target price for the company from $33.00 to $49.00 in a research report on Thursday, May 7th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Agilon Health has an average rating of “Hold” and a consensus target price of $58.73.

Agilon Health Price Performance

The stock has a market capitalization of $1.75 billion, a PE ratio of -4.88 and a beta of 3.02. The business’s 50-day moving average price is $72.32 and its 200 day moving average price is $36.10. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. Research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in AGL. Alpine Global Management LLC bought a new stake in shares of Agilon Health during the 4th quarter valued at $84,000. Cerity Partners LLC bought a new position in shares of Agilon Health in the 4th quarter worth about $277,000. Dynamic Technology Lab Private Ltd lifted its position in Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after acquiring an additional 10,424 shares during the period. Marshall Wace LLP bought a new stake in Agilon Health during the fourth quarter worth about $96,000. Finally, Odyssean LLC bought a new stake in Agilon Health during the fourth quarter worth about $96,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.